Isaac Zacharias - 15 Oct 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
/s/ Wade Estey, as attorney in fact for Isaac Zacharias
Issuer symbol
N/A
Transactions as of
15 Oct 2021
Net transactions value
-$776,700
Form type
4
Filing time
18 Oct 2021, 16:55:53 UTC
Previous filing
16 Sep 2021
Next filing
16 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $468,414 -2,424 -4.4% $193.24 52,996 15 Oct 2021 Direct F1, F2
transaction SWAV Common Stock Sale $155,336 -800 -1.5% $194.17 52,196 15 Oct 2021 Direct F3
transaction SWAV Common Stock Sale $67,727 -347 -0.66% $195.18 51,849 15 Oct 2021 Direct F4
transaction SWAV Common Stock Sale $59,334 -300 -0.58% $197.78 51,549 15 Oct 2021 Direct F5
transaction SWAV Common Stock Sale $25,889 -129 -0.25% $200.69 51,420 15 Oct 2021 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/14/2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $192.68 to $193.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.75 to $194.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $194.89 to $195.55. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.65 to $197.85. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The reported securities were sold at a price of $200.69.